OXM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
OXM is not a good buy right now for an impatient buyer. The stock is in a confirmed downtrend (bearish moving-average stack and worsening MACD), sentiment remains cautious (most analysts sit at Neutral/Hold with targets clustered around the current price), and options positioning shows heavy put open interest (bearish/hedged positioning) alongside extremely elevated implied volatility. While price is sitting right on first support (~36.01), the technical picture does not yet show a clean reversal signal—so the odds favor chop/down over an immediate, dependable bounce.
Trend: Bearish. The moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downside pressure. Momentum: MACD histogram is negative (-0.257) and negatively expanding, suggesting bearish momentum is strengthening rather than fading. RSI: RSI_6 = 38.0 (weak, approaching oversold but not a clear reversal signal). Key levels: Pre-market ~36.05 is essentially sitting on S1 = 36.013. A clean hold and bounce could target the pivot 38.917; above that, resistance sits at R1 41.82. If 36.01 breaks decisively, next support is S2 34.22. Pattern-based odds: Similar-pattern model implies a modest positive bias (70% chance) but small expected moves (+1.23% next day; +4.44% next week; +3.45% next month). Given the current bearish trend indicators, those odds look more like “bounce potential from support” than a confirmed trend change.
Intellectia Proprietary Trading Signals
nudged the target up to $36, aligning with the idea that the stock may be nearing a “priced-in” zone.
Technical trend remains bearish (downtrend MA stack + worsening MACD), so support can still fail.
Options open interest is heavily put-skewed (PCR 3.06), consistent with bearish/defensive positioning.
Recent analyst actions were dominated by price target cuts and cautious commentary tied to demand pressure, tariffs/assortment gaps, and wholesale challenges.
Profitability is still negative (latest quarter shows a loss), and gross margin declined YoY, indicating operating pressure persists.
Latest reported quarter: 2026/Q3. Revenue was $307.3M (-0.22% YoY), essentially flat to slightly down, indicating limited top-line momentum. Profitability: Net income improved YoY but remained negative (-$63.7M), and EPS improved YoY but remained negative (-4.28). The large YoY improvement is off a weaker prior-year base, but the key takeaway is the business is still loss-making. Margins: Gross margin fell to 61.31% (down 4.86% YoY), a negative trend that supports the cautious stance from analysts and the bearish longer-term tape.
Street stance: Mostly Neutral/Hold/Market Perform. Recent trend: Targets were cut materially in mid-Dec 2025 (e.g., Truist to $35 from $50; Telsey to $35 from $52; UBS to $35 from $47; Citi to $33 from $35). UBS later raised slightly to $36 (from $35) on 2026-01-08, but kept Neutral—more of a stabilization move than a bullish turn. Wall Street pros: Investments in stores/distribution/brands can help long-term positioning; some view weak results as already priced in. Wall Street cons: Weak sales/EPS trajectory, guidance pressure, tariff-driven assortment gaps, and a challenged wholesale channel keep sentiment capped and recovery viewed as gradual.
